CAS 863288-34-0

CJC 1295

Description:

CJC-1295 is a synthetic peptide that functions as a growth hormone-releasing hormone (GHRH) analog. It is primarily used in research settings to study its effects on growth hormone secretion and potential therapeutic applications. CJC-1295 is characterized by its ability to stimulate the pituitary gland to release growth hormone, which can lead to increased muscle mass, fat loss, and improved recovery. The peptide has a long half-life due to its modification, which allows for sustained release and prolonged activity in the body. It is typically administered via subcutaneous injection. CJC-1295 is often studied in the context of anti-aging, bodybuilding, and metabolic disorders, although its use in humans outside of research is not approved by regulatory agencies. As with any peptide, the purity, dosage, and administration route are critical for its effectiveness and safety. Researchers must adhere to ethical guidelines and regulations when handling and studying this compound.

Formula: Unspecified

Synonyms:

• <span class="text-smallcaps">L</smallcap>-Lysinamide, <smallcap>L</smallcap>-tyrosyl-<smallcap>D</smallcap>-alanyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-phenylalanyl-<smallcap>L</smallcap>-threonyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-tyrosyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-valyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</span>-arginyl-N⁶-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-
• <span class="text-smallcaps">L</smallcap>-Tyrosyl-<smallcap>D</smallcap>-alanyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-phenylalanyl-<smallcap>L</smallcap>-threonyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-tyrosyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-valyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-arginyl-N⁶-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-<smallcap>L</span>-lysinamide
• Cjc 1295
• L-Tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-L-lysinamide
• L-Lysinamide, L-tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-

CJC-1295

CAS: 863288-34-0

Formula: C₁₅₂H₂₅₂N₄₄O₄₂

Purity: 95%~99%

Color and Shape: White to Off-white Powder

Molecular weight: 3367.897

Ref: BP-BPPG019

CJC-1295

CAS: 863288-34-0

CJC-1295 is a synthetic peptide, which is an analogue of growth hormone-releasing hormone (GHRH). It is synthesized through recombinant DNA technology, which allows for precise control over its sequence and length. This particular peptide is designed to bind to GHRH receptors in the pituitary gland. By activating these receptors, CJC-1295 stimulates the release of growth hormone (GH) into the bloodstream.The primary function of CJC-1295 is to influence the endocrine system, particularly enhancing the release of endogenous growth hormone. It achieves this by increasing the amplitude and frequency of GH pulses without affecting the natural negative feedback mechanisms that regulate GH production. This mode of action distinguishes CJC-1295 from other growth hormone therapies, as it promotes a more physiological pattern of hormone secretion.CJC-1295 is used in various scientific contexts, primarily in research focusing on growth hormone deficiencies, muscle wasting conditions, and certain metabolic disorders. Its ability to increase GH release also makes it a subject of interest in studies related to aging, tissue repair, and regeneration. The longer half-life of CJC-1295 compared to natural GHRH peptides further enhances its applications in research, allowing for more sustained and controlled experimentation.

Purity: Min. 95%

Ref: 3D-FC138107